Laparoscopic Colon Surgery Means Faster Recovery for Some Cancer Patients If colorectal cancer is found through screening, surgery is quickly scheduled to remove the tumor. The standard open surgery ...
Researchers from Switzerland evaluated the effect of standardized coffee intake on postoperative bowel movement after elective laparoscopic colorectal resection. This was a prospective randomized ...
How does laparoscopic surgery compare with open surgery for elective procedures in patients with diverticulitis? The investigators conducted a randomized trial that compared the results of 54 patients ...
Laparoscopic surgery for colon cancer is a safe alternative but further studies are required to clarify its advantages; laparoscopy for rectal cancer requires further scrutiny Laparoscopic colorectal ...
Although in the past decade there have been numerous reports on laparoscopic colorectal surgery for cancer, the majority of these are retrospective. The few published prospective randomized trials ...
A study in this week's issue of THE LANCET suggests that laparoscopy-assisted surgery to treat colon cancer could be more favourable than conventional open surgery, with the potential to reduce ...
Seniors who have minimally invasive laparoscopic surgery for colon cancer are much less likely to end up in a nursing home after being discharged from the hospital than those who have open surgery, a ...
CHICAGO — Laparoscopic surgery for colorectal liver metastases nearly equaled or surpassed open surgery for almost all outcomes, according to results of the randomized, phase 3 OSLO-COMET trial ...
ROCHESTER, Minn. -- When performed by experienced surgeons, minimally invasive laparoscopic surgery is a safe and effective alternative to standard open surgery for most patients with cancer that is ...
Laparoscopy combined with an enhanced recovery pathway is linked to early discharge and low readmission rates of colorectal surgery patients, according to a study in the Journal of the American ...
Modified FOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab beyond first progression in advanced colorectal cancer: CCOG-0801 study. A phase I/II study of biweekly XELIRI plus bevacizumab ...